Prepare for your visit
James W Hung
Ophthalmology · Boston, MA · NPI 1477531416
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$147.76
in general payments reported to CMS, 2019-2025 · $73.75 in 2025
The $73.75 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 3 by amount.
- Glaukos Corporation $109.70
- Thea Pharma INC. $22.35
- Bausch & Lomb Americas INC. $15.71
Drugs and devices associated with these payments
Photrexa Viscous and Photrexa Kxl System (Not Refurbished) Iyuzeh Miebo Xiidra
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw James Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/203019/james-w-hung